ACG, an integrated pharmaceutical and nutraceutical manufacturing company,will launch a process lab in Germany in 2023.
This new process development laboratory will be located at ACG’s XERTECS GmbH site in Mulheim in the southwest of Germany, with the first phase occupying approximately 250 square meters. ACG’s recruitment plan to staff the lab will involve attracting academic talent from local universities, as well as trained and experienced process engineers, pharmacists and lab technicians.
The aim of ACG’s new laboratory is to help customers and partners access the latest knowledge, skills and equipment for all aspects of process development. For example, this facility will help customers test solid dosage optimization limits–and co-create alongside ACG’s team of experts–new process techniques.
The range of available equipment covers areas including feasibility studies, research and development work, pilot-scaling, and tailored in-house technical training courses. Customers will also get to test products from ACG’s portfolio and gain operational and maintenance training on premise.